26 May 2022
Proteome Sciences plc
("Proteome Sciences" or the "Company")
Change of Registered Office
The directors of Proteome Sciences announce that the Company's registered office address has changed to Coveham House, Downside Bridge Road, Cobham, Surrey KT11 3EP with immediate effect.
For further information:
|
Proteome Sciences plc Dr Mariola Soehngen, Chief Executive Officer & |
|
|
Dr Ian Pike, Chief Scientific Officer |
Tel: +44 (0)20 7043 2116 |
|
Allenby Capital Limited (AIM Nominated Adviser & Broker) |
|
|
John Depasquale / Jeremy Porter |
Tel: +44 (0) 20 3328 5656 |
About Proteome Sciences plc. ( www.proteomics.com )
Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant® and TMT®MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator™ provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available.
The Company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany.